Urea C-14

Urea C-14 Overview

Urea C-14 (14C-Urea) is a synthetic, radioactive isotope-labeled organic compound. Chemically, it belongs to the ureas class within the organic carbonic acids and derivatives superclass, consisting of a carbonyl functional group bonded to two amino groups, where the central carbon atom is labeled with the radioactive isotope carbon-14 (14C).

In clinical gastroenterology and diagnostic nuclear medicine, Urea C-14 is classified as an in vivo radioactive diagnostic agent for Helicobacter pylori (H. pylori) identification. It is the substrate for the 14C-Urea Breath Test (14C-UBT), indicated for the qualitative detection of gastric urease activity. It is used for the non-invasive initial diagnosis of H. pylori infection in adult patients, as well as for post-treatment monitoring to confirm bacterial eradication. Marketed under brand names such as PYtest, 14C-Urea emits low-energy beta radiation that is measured in exhaled breath using a liquid scintillation counter or a compact beta-counter.

What Is Urea C-14 and How Does It Work?

Urea C-14 acts as a target enzymatic substrate for bacterial urease, an enzyme produced in abundance by Helicobacter pylori.

Its primary physiological, enzymatic, and diagnostic mechanisms include:

• Absence of Endogenous Human Urease: Human mammalian cells do not synthesize or express urease. Therefore, any rapid hydrolysis of ingested urea within the gastric lumen indicates the presence of urease-producing micro-organisms, specifically H. pylori.
• Enzymatic Cleavage by H. pylori Urease: Upon swallowing a capsule containing 1 microcurie (1 uCi) of 14C-Urea, gastric H. pylori urease rapidly catalyzes the cleavage of labeled urea into labeled carbon dioxide (14CO2) and ammonia (NH3) at the gastric mucosal surface: 14C-Urea + H2O -> 14CO2 + 2 NH3
• Systemic Absorption & Exhalation: The generated 14CO2 dissolves into the gastric mucosa, enters systemic venous circulation, travels to the lungs, and is exhaled in the patient’s breath. Following ingestion, 14CO2 excretion in breath peaks between 10 and 15 minutes and declines thereafter with a biological half-life of approximately 15 minutes.
• Beta-Radiation Measurement: Exhaled breath samples collected 10 to 15 minutes post-ingestion (trapped in a fluid vial or balloon) are analyzed for beta-particle emissions using a liquid scintillation counter or gas-proportional counter. Detectable beta radiation above a specific threshold confirms active H. pylori infection.

Is Urea C-14 FDA Approved?

Yes, Urea C-14 is approved by the US FDA. It received its official New Drug Application approval on May 16, 1997 under the trade name PYtest (manufactured by Tri-Med Specialties / Kimberly-Clark) as an oral radiopharmaceutical diagnostic capsule for the qualitative detection of gastric Helicobacter pylori urease activity in adult patients.

What Is Urea C-14 Used For?

• Qualitative non-invasive detection of gastric urease associated with Helicobacter pylori infection in adult patients presenting with dyspepsia or suspected peptic ulcer disease.
• Post-treatment monitoring to confirm H. pylori eradication (performed at least 4 weeks following completion of antimicrobial/antisecretory therapy).

Before Taking Urea C-14: Contraindications & Precautions

Strictly contraindicated in pregnant women, women planning to become pregnant, and pediatric populations due to exposure to ionizing beta radiation. Patients who are unable to swallow oral capsules whole or follow breath-collection protocols should not receive this test.

Who Should Not Take Urea C-14?

• Pregnant women, women planning to become pregnant, and pediatric patients (due to exposure to ionizing beta radiation; non-radioactive Urea C-13 is the required alternative).
• Patients with a documented hypersensitivity to Urea C-14 or capsule excipients.
• Individuals unable to follow breath-sampling protocols or swallow oral capsules intact.

Urea C-14, Pregnancy & Fertility

Urea C-14 contains carbon-14, a beta-emitting radionuclide with a physical half-life of approximately 5,730 years. Although a single diagnostic dose (1 uCi) imparts a very low radiation dose (less than 1 mrem, equivalent to less than 1 day of natural background radiation), it is strictly contraindicated during pregnancy and breastfeeding to avoid unnecessary radiation exposure to the fetus or infant. The non-radioactive 13C-Urea Breath Test must be used instead for pregnant women and children.

Tell Your Doctor Before Taking Urea C-14

Inform your gastroenterologist if you have recently taken antibiotics, proton pump inhibitors (PPIs), or bismuth compounds, as these medications cause false-negative test results.

Urea C-14 Dosage & Administration

Formulated as an oral capsule containing 1 microcurie of carbon-14 enriched urea. Following a mandatory fast of at least 6 hours, the single adult diagnostic capsule is swallowed intact with 20 mL of lukewarm water.

Standard Urea C-14 Dosing

• Adult Diagnostic Protocol (PYtest): Standard single adult diagnostic dose consists of one capsule containing 1 microcurie (1 uCi) of Urea C-14, swallowed whole with 20 mL of lukewarm water.

How Urea C-14 Is Administered

• Administered strictly via the oral route following a mandatory fasting period of at least 6 hours.
• Test Procedure Steps:

1. Swallow the 1 uCi 14C-Urea capsule intact with 20 mL of water. Do not chew or crush the capsule.
2. Wait quietly for 10 to 15 minutes.
3. Exhale into a breath collection balloon or directly into a fluid trapping solution (hyamine hydroxide or breath card).
4. The sample is transferred to a liquid scintillation counter to quantify beta radiation.

Urea C-14 Clinical Efficacy & Research

Clinical studies demonstrate that the 14C-Urea Breath Test achieves high diagnostic accuracy, with sensitivity and specificity exceeding 95% for identifying active H. pylori infection in untreated patients. Comparative clinical trials confirm that 14C-UBT is superior to serological antibody testing because it detects active bacterial colonization rather than past immune exposure, making it an effective tool for verifying cure following antibiotic eradication regimens.

Urea C-14 Side Effects & Safety Profile

Adverse reactions following a single diagnostic dose are extremely rare ($<1/100,000$). Common minor complaints include mild, transient stomach upset or temporary difficulty swallowing the capsule intact.

Common Urea C-14 Side Effects

• Side effects are extremely rare. Mild, transient stomach upset or difficulty swallowing the capsule may occur occasionally.

Serious Urea C-14 Adverse Events

• Severe adverse events or systemic toxicity have not been reported following single diagnostic doses. Hypersensitivity reactions occur in fewer than 1 in 100,000 administrations.

Managing Urea C-14 Side Effects

Because the single diagnostic dose is minute (1 uCi) and rapidly cleared, clinical management of side effects is rarely required. Swallowing the capsule with adequate water prevents temporary esophageal hesitation.

Urea C-14 Drug Interactions & What to Avoid

Co-administration with agents that suppress H. pylori bacterial density or urease activity causes false-negative diagnostic results.

Medications Causing False-Negative Results

• Antibiotics (e.g., Amoxicillin, Clarithromycin, Metronidazole): Suppress H. pylori bacterial counts, leading to false-negative UBT results. Discontinue antibiotics for at least 4 weeks prior to testing.
• Proton Pump Inhibitors (PPIs – e.g., Omeprazole, Esomeprazole): Directly suppress H. pylori urease activity and gastric acid. Discontinue PPIs for at least 2 weeks prior to testing.
• Bismuth Preparations (e.g., Pepto-Bismol, Pylera): Exhibit direct anti-bacterial activity against H. pylori. Discontinue bismuth for at least 2 to 4 weeks prior to testing.
• H2-Receptor Antagonists (e.g., Famotidine): May weakly reduce test sensitivity; holding H2-blockers for 24 to 48 hours prior to testing is recommended in some clinical protocols.

Urea C-14, Food & Alcohol

Fast completely from food and liquids for at least 6 hours prior to taking the test. Ingesting food shortly before the test delays capsule dissolution and interferes with 14CO2 kinetic collection.

Urea C-14: Missed Dose, Overdose & Storage

Because Urea C-14 is administered as a single, one-time diagnostic reagent in a clinical facility, missed-dose protocols do not apply. A single capsule contains $1\text{ }\mu\text{Ci}$ of radiation, which carries minimal clinical risk; accidental ingestion of multiple capsules increases total beta-radiation exposure proportionally, managed via forced hydration to promote rapid renal clearance of unmetabolized labeled urea.

Missed Dose of Urea C-14

Because Urea C-14 is administered as a single, one-time diagnostic reagent in a clinical facility, missed dose protocols do not apply.

Urea C-14 Overdose & Emergency

A single capsule contains 1 uCi of radiation, which is clinically negligible. Massive accidental ingestion of multiple capsules would increase radiation exposure proportionally, but metabolic excretion in breath and urine ensures rapid clearance. Provide supportive clinical care and hydration.

How to Store Urea C-14

Store PYtest capsules at controlled room temperature between 15 degrees C and 30 degrees C (59 degrees F to 86 degrees F). Protect from excessive moisture and direct light according to radiopharmaceutical handling guidelines. Keep strictly out of reach of children.

Urea C-14 Patient Management & Monitoring

Verify that all antibiotics and bismuth preparations have been held for at least 4 weeks, PPIs held for 2 weeks, and that the patient has completed a 6-hour pre-test fast. Confirm that the patient is not pregnant or breastfeeding before administering the radiopharmaceutical capsule.

Preparation Checklist Before the Test

• Verify that all antibiotics and bismuth drugs have been stopped for at least 4 weeks.
• Verify that all proton pump inhibitors (PPIs) have been stopped for at least 2 weeks.
• Fast from food and drink for at least 6 hours prior to test arrival.
• Confirm the patient is not pregnant or breastfeeding.

Monitoring During Urea C-14 Testing

No hemodynamic or laboratory monitoring is required during testing.

Urea C-14 Do’s and Don’ts

• Do inform your doctor if you are pregnant, nursing, or taking heartburn medications.
• Do fast for at least 6 hours before the test.
• Do swallow the capsule whole with water.
• Do not chew, crush, or dissolve the capsule before swallowing.
• Do not perform this test on pregnant women or children (use 13C-Urea instead).

Frequently Asked Questions

References

• DrugBank Database – Urea C-14 Clinical Profile (DB09513)
• Official FDA Prescribing Information – PYtest (Urea C-14 Diagnostic Capsule)

Legal Disclaimer

The detailed medical and chemical information provided on this specific web page is intended strictly for educational and informational purposes regarding complex pharmacological mechanisms. It absolutely does not constitute professional medical advice, medical diagnosis, or specific treatment recommendations. Always consult a licensed healthcare provider before making any personal decisions regarding complex medical conditions, medication adjustments, or dietary changes.